XML 40 R29.htm IDEA: XBRL DOCUMENT v3.26.1
Research and Development Collaborations (Details) - USD ($)
$ in Thousands
1 Months Ended 3 Months Ended
Jun. 30, 2003
Mar. 31, 2026
Mar. 31, 2025
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Royalty fees receivable (as a percent)   10.00%  
Revenues, net   $ 0 $ 2,380
Aurigene | IRAK4, PD1/VISTA, and PD1/TIM3 Programs      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Waived payment of milestone and other payments (up to)   $ 42,500  
Genentech, Inc.      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Percentage of royalty rate decrease 2.00%    
Genentech, Inc. | Royalties      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Revenues, net     $ 2,400
Genentech, Inc. | Minimum      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Percentage of royalty on net sales 5.00%    
Genentech, Inc. | Maximum      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Percentage of royalty on net sales 7.50%